Trial Profile
Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Lamivudine (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- 01 Dec 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 01 Apr 2011 Two-year results published in the Hepatology.
- 17 Nov 2009 New trial record